Senior Vice President and Chief Supply Chain Officer · BALCHEM CORP (BCPC)

Martin Reid

A named executive officer of BALCHEM in every fiscal year CompBrief holds from FY2021 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,100,737

Salary $437,423Stock awards $319,777

FY2021: $1,432,728

4th of 6 named executive officers at Balchem by FY2022 total.

6 named officers on file for BALCHEM, FY2022

Martin Reid’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • BCPC’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BALCHEM’s whole pay program stands against its peers

  • BALCHEM’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BCPC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2023 (DEF 14A).

Free

Get Martin Reid’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Martin Reid compensation by year

BALCHEM Summary Compensation Table · all 2 fiscal years held
In US dollars, as BALCHEM reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022
Salary$375,962$437,423
Bonus$0$0
Stock awards$499,872$319,777
Option awards$191,128$108,701
Non-equity incentive$339,539$202,836
Pension and deferred compensation$0$0
All other$26,227$32,000
Total$1,432,728$1,100,737

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BALCHEM CORP DEF 14A filed April 28, 2023, accession 0001140361-23-021578, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BALCHEM CORP filed document, accession 0001140361-23-021578. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2023.

$1.4M
$1.1M
FY21
FY22
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU2,400$404,640—
RSU1,690$284,934—
Option3,300—$119.13
Option2,500—$118.96

Per the Outstanding Equity Awards at Fiscal Year-End table in BALCHEM CORP's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

BALCHEM’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Ted HarrisChairman, President and Chief Executive Officer$11,948,265
Martin BengtssonExecutive Vice President and Chief Financial Officer$1,666,735
Jim HydeFormer Senior Vice President and General Manager, Human Health and Nutrition$1,202,980
Martin Reid · this pageSenior Vice President and Chief Supply Chain Officer$1,100,737
Jonathan GriffinSenior Vice President and General Manager, Animal Nutrition and Health$1,006,147
Hatsuki MiyataExecutive Vice President, General Counsel and Secretary$975,667

The full BALCHEM compensation record

free company brief

This page is one person within BALCHEM's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BALCHEM proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BALCHEM's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Martin Reid's compensation dossier · One-time report. No refunds.